Single-step scalable-throughput molecular screening for Huntington disease

Clinical Chemistry

Volumn 54, Issue 6, 2008, Pages 964-972

  Teo, Clara R L ^a   Wang, Wen ^b   Hai, Yang Law ^c   Lee, Caroline G ^a   Chong, Samuel S ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN;

ALLELE; AMPLICON; ARTICLE; AUTOMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA DETERMINATION; GENE; GENE AMPLIFICATION; HTT GENE; HUMAN; HUNTINGTON CHOREA; PENETRANCE; POLYMERASE CHAIN REACTION; SCREENING TEST; SYMPTOMATOLOGY; VALIDATION PROCESS;

AUTOANALYSIS; DNA; ELECTROPHORESIS, CAPILLARY; GENOTYPE; HUMANS; HUNTINGTON DISEASE; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TRANSITION TEMPERATURE; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 44849100248     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.096503     Document Type: Article

References (20)

1. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72:971-83.
2. Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 1993;4:398-403.
3. Trottier Y, Biancalana V, Mandel JL. Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset. J Med Genet 1994;31:377-82.
4. ACMG/ASHG statement. Laboratory guidelines for Huntington disease genetic testing. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group. Am J Hum Genet 1998;62:1243-7.
5. Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A 2004;101:3498-503.
6. Semaka A, Creighton S, Warby S, Hayden MR. Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet 2006;70:283-94.
7. n repeats causing Huntington's disease. Hum Mol Genet 1993;2:637.
8. Castellvi-Bel S, Matilla T, Banchs MI, Kruyer H, Corral J, Mila M, Estivill X. Chemiluminescent detection of blotted PCR products (CB-PCR) of two CAG dynamic mutations (Huntington's disease and spinocerebellar ataxia type 1). J Med Genet 1994;31:654-5.
9. Panagopoulos I, Lassen C, Kristoffersson U, Aman P. A novel PCR-based approach for the detection of the Huntington disease associated trinucleotide repeat expansion. Hum Mutat 1999;13:232-6.
10. Hecimovic S, Vlasic J, Barisic L, Markovic D, Culic V, Pavelic K. A simple and rapid analysis of triplet repeat diseases by expand long PCR. Clin Chem Lab Med 2001;39:1259-62.
11. n repeats causing Huntington disease by fluorescent PCR. Clin Chem 1997;43:2422-3.
12. Williams LC, Hegde MR, Herrera G, Stapleton PM, Love DR. Comparative semi-automated analysis of (CAG) repeats in the Huntington disease gene: use of internal standards. Mol Cell Probes 1999;13:283-9.
13. Gundry CN, Wittwer CT. SYBR Green I analysis of the trinucleotide repeat responsible for Huntington's disease. In: Dietmaier W, Wittwer C, Sivasubramanian N, eds. Rapid cycle real-time PCR methods and applications genetics and oncology. Berlin: Springer Verlag, 2002:57-63.
14. Andrew SE, Goldberg YP, Theilmann J, Zeisler J, Hayden MR. A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing. Hum Mol Genet 1994;3:65-7.
15. Rubinsztein DC, Leggo J, Barton DE, Ferguson-Smith MA. Site of (CCG) polymorphism in the HD gene. Nat Genet 1993;5:214-5.
16. Margolis RL, Ross CA. Diagnosis of Huntington disease. Clin Chem 2003;49:1726-32.
17. Liew M, Seipp M, Durtschi J, Margraf RL, Dames S, Erali M, et al. Closed-tube SNP genotyping without labeled probes/a comparison between unlabeled probe and amplicon melting. Am J Clin Pathol 2007;127:341-8.
18. Seipp MT, Durtschi JD, Liew MA, Williams J, Damjanovich K, Pont-Kingdon G, et al. Unlabeled oligonucleotides as internal temperature controls for genotyping by amplicon melting. J Mol Diagn 2007;9:284-9.
19. Cannella M, Gellera C, Maglione V, Giallonardo P, Cislaghi G, Muglia M, et al. The gender effect in juvenile Huntington disease patients of Italian origin. Am J Med Genet B Neuropsychiatr Genet 2004;125:92-8.
20. Squitieri F, Frati L, Ciarmiello A, Lastoria S, Quarrell O. Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease? Mech Ageing Dev 2006;127:208-12.